Nordea Investment Management’s Arcus Biosciences RCUS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.63M | Buy |
319,899
+46,776
| +17% | +$385K | ﹤0.01% | 683 |
|
|
2025
Q1 | $2.08M | Buy |
273,123
+54,193
| +25% | +$413K | ﹤0.01% | 696 |
|
|
2024
Q4 | $3.24M | Buy |
218,930
+5,246
| +2% | +$77.7K | ﹤0.01% | 609 |
|
|
2024
Q3 | $3.31M | Sell |
213,684
-10,267
| -5% | -$159K | ﹤0.01% | 599 |
|
|
2024
Q2 | $3.37M | Sell |
223,951
-35,421
| -14% | -$533K | ﹤0.01% | 604 |
|
|
2024
Q1 | $4.89M | Buy |
259,372
+53,944
| +26% | +$1.02M | 0.01% | 543 |
|
|
2023
Q4 | $3.95M | Sell |
205,428
-6,356
| -3% | -$122K | 0.01% | 582 |
|
|
2023
Q3 | $3.79M | Buy |
211,784
+24,121
| +13% | +$432K | 0.01% | 562 |
|
|
2023
Q2 | $3.79M | Sell |
187,663
-75,423
| -29% | -$1.52M | 0.01% | 574 |
|
|
2023
Q1 | $4.81M | Sell |
263,086
-2,428
| -0.9% | -$44.4K | 0.01% | 528 |
|
|
2022
Q4 | $5.49M | Buy |
+265,514
| New | +$5.49M | 0.01% | 490 |
|